

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.69516637 |
| 2 | daunorubicin metabolic process (GO:0044597) | 5.19183958 |
| 3 | polyketide metabolic process (GO:0030638) | 5.19183958 |
| 4 | doxorubicin metabolic process (GO:0044598) | 5.19183958 |
| 5 | response to peptidoglycan (GO:0032494) | 4.89492297 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.88998333 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.75086375 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.75086375 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 4.66069868 |
| 10 | positive regulation of mast cell activation (GO:0033005) | 4.21636379 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.10256169 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.10256169 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.10256169 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.10256169 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.10256169 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.10256169 |
| 17 | B cell mediated immunity (GO:0019724) | 3.80437190 |
| 18 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.78784354 |
| 19 | positive regulation of mast cell degranulation (GO:0043306) | 3.78784354 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 3.72622235 |
| 21 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.71298052 |
| 22 | detection of bacterium (GO:0016045) | 3.67382888 |
| 23 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.62434756 |
| 24 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.59800341 |
| 25 | respiratory burst (GO:0045730) | 3.59199352 |
| 26 | neutrophil activation (GO:0042119) | 3.57557609 |
| 27 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.56480248 |
| 28 | natural killer cell mediated immunity (GO:0002228) | 3.56480248 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.56412439 |
| 30 | positive regulation of interferon-alpha production (GO:0032727) | 3.56021905 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.55389021 |
| 32 | granulocyte activation (GO:0036230) | 3.50272676 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.47265694 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.45808402 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.44420691 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.43900359 |
| 37 | regulation of platelet aggregation (GO:0090330) | 3.42799355 |
| 38 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.42035718 |
| 39 | leukocyte degranulation (GO:0043299) | 3.38272924 |
| 40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.37177517 |
| 41 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.36306987 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.35776044 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.35745592 |
| 44 | negative regulation of phagocytosis (GO:0050765) | 3.34083698 |
| 45 | neutrophil mediated immunity (GO:0002446) | 3.27831696 |
| 46 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.26956445 |
| 47 | defense response to protozoan (GO:0042832) | 3.26697844 |
| 48 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.26557183 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.22801701 |
| 50 | regulation of leukocyte degranulation (GO:0043300) | 3.21661711 |
| 51 | macrophage activation (GO:0042116) | 3.20930128 |
| 52 | thrombin receptor signaling pathway (GO:0070493) | 3.20265913 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 3.19408984 |
| 54 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.18681331 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.18681331 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 3.16886705 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.15456201 |
| 58 | positive regulation of antigen processing and presentation (GO:0002579) | 3.12830878 |
| 59 | regulation of platelet activation (GO:0010543) | 3.12462863 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.11232329 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.08490243 |
| 62 | pinocytosis (GO:0006907) | 3.06300434 |
| 63 | response to interferon-beta (GO:0035456) | 3.05266412 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04972975 |
| 65 | positive regulation of leukocyte degranulation (GO:0043302) | 3.03982392 |
| 66 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.03120212 |
| 67 | detection of biotic stimulus (GO:0009595) | 3.02958519 |
| 68 | cytidine deamination (GO:0009972) | 3.02733311 |
| 69 | cytidine metabolic process (GO:0046087) | 3.02733311 |
| 70 | cytidine catabolic process (GO:0006216) | 3.02733311 |
| 71 | type I interferon signaling pathway (GO:0060337) | 3.02701257 |
| 72 | cellular response to type I interferon (GO:0071357) | 3.02701257 |
| 73 | reactive oxygen species biosynthetic process (GO:1903409) | 3.02340752 |
| 74 | interferon-gamma production (GO:0032609) | 3.02257436 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.02253139 |
| 76 | response to type I interferon (GO:0034340) | 3.00334194 |
| 77 | response to interleukin-15 (GO:0070672) | 2.97815270 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97568707 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.96498154 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.96498154 |
| 81 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95281340 |
| 82 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94754235 |
| 83 | response to protozoan (GO:0001562) | 2.94070990 |
| 84 | germinal center formation (GO:0002467) | 2.93772049 |
| 85 | leukocyte mediated cytotoxicity (GO:0001909) | 2.92923428 |
| 86 | positive regulation of defense response to virus by host (GO:0002230) | 2.92833495 |
| 87 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.92078449 |
| 88 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90795070 |
| 89 | response to host immune response (GO:0052572) | 2.90795070 |
| 90 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.89403102 |
| 91 | response to interferon-alpha (GO:0035455) | 2.89018563 |
| 92 | peptide catabolic process (GO:0043171) | 2.84085487 |
| 93 | negative regulation of T cell mediated immunity (GO:0002710) | 2.84056159 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 2.83326799 |
| 95 | regulation of B cell differentiation (GO:0045577) | 2.82470122 |
| 96 | mast cell activation (GO:0045576) | 2.82436997 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.81181048 |
| 98 | negative regulation of interleukin-17 production (GO:0032700) | 2.80462301 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79909289 |
| 100 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.79421939 |
| 101 | cellular response to interleukin-15 (GO:0071350) | 2.78054415 |
| 102 | myeloid dendritic cell activation (GO:0001773) | 2.76888187 |
| 103 | cellular response to interferon-beta (GO:0035458) | 2.76471454 |
| 104 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.75553517 |
| 105 | regulation of germinal center formation (GO:0002634) | 2.74862106 |
| 106 | positive regulation of interferon-beta production (GO:0032728) | 2.74550591 |
| 107 | leukocyte aggregation (GO:0070486) | 2.73641947 |
| 108 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.72112056 |
| 109 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.71559962 |
| 110 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.71069147 |
| 111 | regulation of hypersensitivity (GO:0002883) | 2.70486980 |
| 112 | lymphocyte mediated immunity (GO:0002449) | 2.69313954 |
| 113 | superoxide anion generation (GO:0042554) | 2.68612347 |
| 114 | positive regulation of type 2 immune response (GO:0002830) | 2.68517440 |
| 115 | regulation of interleukin-17 production (GO:0032660) | 2.67625845 |
| 116 | positive regulation of macrophage differentiation (GO:0045651) | 2.65682798 |
| 117 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.65627797 |
| 118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65342198 |
| 119 | regulation of regulatory T cell differentiation (GO:0045589) | 2.65142395 |
| 120 | regulation of mast cell activation (GO:0033003) | 2.64110482 |
| 121 | regulation of regulated secretory pathway (GO:1903305) | 2.64073398 |
| 122 | response to host (GO:0075136) | 2.63497013 |
| 123 | response to host defenses (GO:0052200) | 2.63497013 |
| 124 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.63497013 |
| 125 | regulation of necroptotic process (GO:0060544) | 2.62593798 |
| 126 | regulation of memory T cell differentiation (GO:0043380) | 2.62088219 |
| 127 | phagocytosis, engulfment (GO:0006911) | 2.62054307 |
| 128 | regulation of mast cell degranulation (GO:0043304) | 2.61633191 |
| 129 | microglial cell activation (GO:0001774) | 2.61170789 |
| 130 | dendritic cell differentiation (GO:0097028) | 2.60696762 |
| 131 | protein localization to kinetochore (GO:0034501) | 2.58263850 |
| 132 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.56633618 |
| 133 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.56432409 |
| 134 | myeloid leukocyte mediated immunity (GO:0002444) | 2.56290883 |
| 135 | leukocyte mediated immunity (GO:0002443) | 2.55713694 |
| 136 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.54285598 |
| 137 | T-helper 1 type immune response (GO:0042088) | 2.54154109 |
| 138 | cellular extravasation (GO:0045123) | 2.53791105 |
| 139 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.53790850 |
| 140 | detection of other organism (GO:0098543) | 2.53712313 |
| 141 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.53480494 |
| 142 | myeloid dendritic cell differentiation (GO:0043011) | 2.51280079 |
| 143 | regulation of chemokine biosynthetic process (GO:0045073) | 2.50953945 |
| 144 | negative regulation of viral genome replication (GO:0045071) | 2.50930585 |
| 145 | regulation of RIG-I signaling pathway (GO:0039535) | 2.48862551 |
| 146 | negative regulation of growth of symbiont in host (GO:0044130) | 2.48006843 |
| 147 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.48006843 |
| 148 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.48006843 |
| 149 | regulation of growth of symbiont in host (GO:0044126) | 2.48006843 |
| 150 | myeloid leukocyte activation (GO:0002274) | 2.46239016 |
| 151 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.46136130 |
| 152 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.45415157 |
| 153 | cytokine secretion (GO:0050663) | 2.44928279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.58058590 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.00462578 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.90747672 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.71797790 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.42298499 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19419031 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16832122 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05547497 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.95575176 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88160445 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77847346 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60966796 |
| 13 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.60246211 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.49711956 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.37021121 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35839707 |
| 17 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.24431119 |
| 18 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.24431119 |
| 19 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.24431119 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.20261774 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19683437 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.09417541 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02994652 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01556178 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99241458 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97051504 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95774071 |
| 28 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.94346487 |
| 29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.92461927 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86910080 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86770433 |
| 32 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85103100 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.84579270 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81786425 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78616059 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75329473 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72452118 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.72273472 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 1.67615542 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64631956 |
| 41 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64032764 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60387031 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57167573 |
| 44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.52805529 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.50574845 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48915947 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43607915 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.42822365 |
| 49 | GATA2_19941826_ChIP-Seq_K562_Human | 1.42447836 |
| 50 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42064495 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40929546 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40668074 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40418406 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39985585 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39490729 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35651470 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35405051 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34441129 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.31998302 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31557946 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.29585520 |
| 62 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26689159 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24808999 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24749264 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.24502555 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24421459 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23687111 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20801268 |
| 69 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.20273411 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18840968 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17822866 |
| 72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17535034 |
| 73 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.14765747 |
| 74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14297850 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14173188 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12385040 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06645369 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05932305 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04949133 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04501222 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04278812 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04155287 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03727066 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02816699 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02592958 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02460183 |
| 87 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99633897 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99586463 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97345696 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96917682 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92653435 |
| 92 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.91626300 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91027712 |
| 94 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90872361 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.88240012 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88224205 |
| 97 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87371527 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86920634 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86733731 |
| 100 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.85610149 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85419840 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84800788 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84056742 |
| 104 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.83737524 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82545271 |
| 106 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82542909 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82485812 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80889438 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80403939 |
| 110 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.79703567 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79549143 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78877327 |
| 113 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78651348 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.78338517 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77971607 |
| 116 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.77520713 |
| 117 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.77520713 |
| 118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76850332 |
| 119 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.76641347 |
| 120 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.76469723 |
| 121 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.76153337 |
| 122 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75859946 |
| 123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75586782 |
| 124 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75560160 |
| 125 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.75162300 |
| 126 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.73850116 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 0.73114605 |
| 128 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.70955489 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70048852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.01696980 |
| 2 | MP0003436_decreased_susceptibility_to | 3.20580164 |
| 3 | MP0009785_altered_susceptibility_to | 3.00239518 |
| 4 | MP0006082_CNS_inflammation | 2.79638522 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.79264283 |
| 6 | MP0002419_abnormal_innate_immunity | 2.65478643 |
| 7 | MP0005025_abnormal_response_to | 2.58339086 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.54859150 |
| 9 | * MP0005000_abnormal_immune_tolerance | 2.50883214 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.35784148 |
| 11 | MP0005671_abnormal_response_to | 2.35653849 |
| 12 | MP0000685_abnormal_immune_system | 2.34119499 |
| 13 | * MP0001800_abnormal_humoral_immune | 2.33327394 |
| 14 | MP0001790_abnormal_immune_system | 2.29209603 |
| 15 | MP0005387_immune_system_phenotype | 2.29209603 |
| 16 | * MP0002723_abnormal_immune_serum | 2.17869925 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.15591131 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.13356481 |
| 19 | * MP0001819_abnormal_immune_cell | 2.08146129 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.07451854 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.07095901 |
| 22 | MP0003724_increased_susceptibility_to | 2.06002297 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.99801490 |
| 24 | MP0008004_abnormal_stomach_pH | 1.99421043 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.91068178 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.84312770 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.83719050 |
| 28 | MP0002405_respiratory_system_inflammati | 1.82036224 |
| 29 | MP0003303_peritoneal_inflammation | 1.78009549 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.75389551 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.75389551 |
| 32 | MP0001853_heart_inflammation | 1.74379320 |
| 33 | MP0002254_reproductive_system_inflammat | 1.72351376 |
| 34 | MP0008057_abnormal_DNA_replication | 1.71106468 |
| 35 | MP0000490_abnormal_crypts_of | 1.69224184 |
| 36 | * MP0002398_abnormal_bone_marrow | 1.67720865 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.66914506 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.66297909 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.64637409 |
| 40 | * MP0000716_abnormal_immune_system | 1.64429508 |
| 41 | MP0009278_abnormal_bone_marrow | 1.63437476 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.59016517 |
| 43 | MP0000343_altered_response_to | 1.56035561 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.55757569 |
| 45 | MP0008260_abnormal_autophagy | 1.54761395 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.54318348 |
| 47 | MP0002006_tumorigenesis | 1.53271699 |
| 48 | MP0003448_altered_tumor_morphology | 1.52101047 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.50803842 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.48884772 |
| 51 | MP0000858_altered_metastatic_potential | 1.47343015 |
| 52 | * MP0002429_abnormal_blood_cell | 1.45983757 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.45940777 |
| 54 | MP0002722_abnormal_immune_system | 1.45101017 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.42641100 |
| 56 | MP0004947_skin_inflammation | 1.41374361 |
| 57 | MP0004808_abnormal_hematopoietic_stem | 1.40932968 |
| 58 | MP0008469_abnormal_protein_level | 1.36349843 |
| 59 | MP0005310_abnormal_salivary_gland | 1.32767141 |
| 60 | MP0003866_abnormal_defecation | 1.29982404 |
| 61 | MP0009764_decreased_sensitivity_to | 1.27814039 |
| 62 | MP0001851_eye_inflammation | 1.26726123 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.25251077 |
| 64 | MP0003011_delayed_dark_adaptation | 1.21564213 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.20773178 |
| 66 | MP0010307_abnormal_tumor_latency | 1.16573418 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.14624853 |
| 68 | MP0003828_pulmonary_edema | 1.14420621 |
| 69 | MP0004510_myositis | 1.13672839 |
| 70 | MP0003186_abnormal_redox_activity | 1.13048614 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.12575097 |
| 72 | MP0005451_abnormal_body_composition | 1.11379262 |
| 73 | MP0003075_altered_response_to | 1.08811860 |
| 74 | MP0003693_abnormal_embryo_hatching | 1.07959904 |
| 75 | MP0003566_abnormal_cell_adhesion | 1.01963878 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.01351693 |
| 77 | MP0003077_abnormal_cell_cycle | 1.01168046 |
| 78 | MP0008007_abnormal_cellular_replicative | 1.00853266 |
| 79 | MP0005257_abnormal_intraocular_pressure | 1.00014376 |
| 80 | MP0000371_diluted_coat_color | 0.98703387 |
| 81 | MP0004957_abnormal_blastocyst_morpholog | 0.95855803 |
| 82 | MP0010094_abnormal_chromosome_stability | 0.95558818 |
| 83 | MP0006292_abnormal_olfactory_placode | 0.94209907 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.92984350 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.92566649 |
| 86 | MP0002132_abnormal_respiratory_system | 0.91555586 |
| 87 | MP0001873_stomach_inflammation | 0.90672683 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.89520843 |
| 89 | MP0009763_increased_sensitivity_to | 0.89389950 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.87812981 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.87625271 |
| 92 | MP0005023_abnormal_wound_healing | 0.87138514 |
| 93 | MP0005390_skeleton_phenotype | 0.85709247 |
| 94 | MP0006054_spinal_hemorrhage | 0.81911104 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.81617196 |
| 96 | MP0001663_abnormal_digestive_system | 0.80297564 |
| 97 | MP0000313_abnormal_cell_death | 0.79414997 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.77705865 |
| 99 | MP0002139_abnormal_hepatobiliary_system | 0.77234032 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.77208598 |
| 101 | MP0003045_fibrosis | 0.76944415 |
| 102 | MP0005165_increased_susceptibility_to | 0.76929663 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.75799413 |
| 104 | MP0005164_abnormal_response_to | 0.74269185 |
| 105 | MP0002933_joint_inflammation | 0.74096328 |
| 106 | MP0009840_abnormal_foam_cell | 0.73166300 |
| 107 | MP0003795_abnormal_bone_structure | 0.72800366 |
| 108 | MP0003638_abnormal_response/metabolism_ | 0.72223005 |
| 109 | MP0004381_abnormal_hair_follicle | 0.70142766 |
| 110 | MP0000249_abnormal_blood_vessel | 0.69653051 |
| 111 | MP0000604_amyloidosis | 0.69426177 |
| 112 | MP0004883_abnormal_blood_vessel | 0.68994935 |
| 113 | MP0002095_abnormal_skin_pigmentation | 0.68815287 |
| 114 | MP0008874_decreased_physiological_sensi | 0.68630808 |
| 115 | MP0005166_decreased_susceptibility_to | 0.68187060 |
| 116 | MP0003111_abnormal_nucleus_morphology | 0.67860302 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.66870708 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.65417413 |
| 119 | MP0003252_abnormal_bile_duct | 0.64351353 |
| 120 | MP0003690_abnormal_glial_cell | 0.60711024 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.59155135 |
| 122 | MP0000609_abnormal_liver_physiology | 0.56908660 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.55826086 |
| 124 | MP0004484_altered_response_of | 0.55601030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.36549474 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.85143902 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.40580249 |
| 4 | Myositis (HP:0100614) | 4.57297533 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.42391789 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.35688427 |
| 7 | Purpura (HP:0000979) | 4.09756810 |
| 8 | Abnormal platelet volume (HP:0011876) | 3.97700985 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.90365855 |
| 10 | Orchitis (HP:0100796) | 3.81687819 |
| 11 | Increased mean platelet volume (HP:0011877) | 3.75967000 |
| 12 | Menorrhagia (HP:0000132) | 3.74218033 |
| 13 | Gingivitis (HP:0000230) | 3.63981988 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.57309245 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.57309245 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.57309245 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.49158839 |
| 18 | Recurrent skin infections (HP:0001581) | 3.48900567 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.42840853 |
| 20 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.37405503 |
| 21 | Chromsome breakage (HP:0040012) | 3.35754516 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.26290884 |
| 23 | Cellulitis (HP:0100658) | 3.17721177 |
| 24 | Obstructive lung disease (HP:0006536) | 3.08553866 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.08553866 |
| 26 | T lymphocytopenia (HP:0005403) | 3.04684450 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.99054676 |
| 28 | Abnormality of T cell number (HP:0011839) | 2.97334355 |
| 29 | Recurrent viral infections (HP:0004429) | 2.97090496 |
| 30 | Periodontitis (HP:0000704) | 2.96894306 |
| 31 | Petechiae (HP:0000967) | 2.91344039 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 2.90421846 |
| 33 | Reduced antithrombin III activity (HP:0001976) | 2.88074570 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.87139235 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.83857620 |
| 36 | Vasculitis (HP:0002633) | 2.81025231 |
| 37 | Optic neuritis (HP:0100653) | 2.80672728 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.80672728 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 2.79531167 |
| 40 | Agnosia (HP:0010524) | 2.77011481 |
| 41 | Pustule (HP:0200039) | 2.72432589 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.68294059 |
| 43 | Prostate neoplasm (HP:0100787) | 2.63394500 |
| 44 | Abnormality of the prostate (HP:0008775) | 2.62808987 |
| 45 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.56682848 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.53367282 |
| 47 | Meningitis (HP:0001287) | 2.51254377 |
| 48 | Thrombocytosis (HP:0001894) | 2.51078217 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.48294996 |
| 50 | Abnormality of T cells (HP:0002843) | 2.48098400 |
| 51 | Gingival bleeding (HP:0000225) | 2.47724475 |
| 52 | Urticaria (HP:0001025) | 2.47043242 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.46470640 |
| 54 | IgM deficiency (HP:0002850) | 2.45323127 |
| 55 | Stomatitis (HP:0010280) | 2.44853748 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.44438409 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.44365861 |
| 58 | Osteomyelitis (HP:0002754) | 2.43870641 |
| 59 | Leukocytosis (HP:0001974) | 2.42527252 |
| 60 | Cheilitis (HP:0100825) | 2.38899711 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 2.37963984 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.32871400 |
| 63 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.31362076 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.30639516 |
| 65 | Axonal loss (HP:0003447) | 2.29301955 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26506587 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26506587 |
| 68 | Joint swelling (HP:0001386) | 2.25844236 |
| 69 | Epistaxis (HP:0000421) | 2.25674399 |
| 70 | Basal ganglia calcification (HP:0002135) | 2.24895970 |
| 71 | Nasal polyposis (HP:0100582) | 2.24380161 |
| 72 | Disinhibition (HP:0000734) | 2.23880224 |
| 73 | Loss of speech (HP:0002371) | 2.22831127 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.21392407 |
| 75 | Chest pain (HP:0100749) | 2.21178058 |
| 76 | Episodic fever (HP:0001954) | 2.21053782 |
| 77 | Hypochromic anemia (HP:0001931) | 2.20403895 |
| 78 | Pulmonary embolism (HP:0002204) | 2.20354561 |
| 79 | Conjunctival telangiectasia (HP:0000524) | 2.19788494 |
| 80 | Chronic otitis media (HP:0000389) | 2.18516265 |
| 81 | Recurrent pneumonia (HP:0006532) | 2.16528484 |
| 82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15232717 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.13876200 |
| 84 | Anorexia (HP:0002039) | 2.13503960 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.13213031 |
| 86 | Gangrene (HP:0100758) | 2.12849140 |
| 87 | Aplastic anemia (HP:0001915) | 2.12786138 |
| 88 | Abnormality of the nasal mucosa (HP:0000433) | 2.12616278 |
| 89 | Vertigo (HP:0002321) | 2.11772737 |
| 90 | Myelodysplasia (HP:0002863) | 2.11633071 |
| 91 | Hemoptysis (HP:0002105) | 2.10836681 |
| 92 | Bruising susceptibility (HP:0000978) | 2.10581663 |
| 93 | Poor head control (HP:0002421) | 2.09369930 |
| 94 | Fatigue (HP:0012378) | 2.09295507 |
| 95 | Eosinophilia (HP:0001880) | 2.07960763 |
| 96 | Premature loss of primary teeth (HP:0006323) | 2.07391936 |
| 97 | Agammaglobulinemia (HP:0004432) | 2.07082833 |
| 98 | Glomerulopathy (HP:0100820) | 2.06003359 |
| 99 | Myocardial infarction (HP:0001658) | 2.02590004 |
| 100 | Prolonged bleeding time (HP:0003010) | 2.02001597 |
| 101 | Increased serum ferritin (HP:0003281) | 2.01980273 |
| 102 | Bilateral microphthalmos (HP:0007633) | 1.99821797 |
| 103 | Polyneuropathy (HP:0001271) | 1.98136990 |
| 104 | Recurrent lower respiratory tract infections (HP:0002783) | 1.97432509 |
| 105 | Granulocytopenia (HP:0001913) | 1.95732886 |
| 106 | Increased IgM level (HP:0003496) | 1.95505177 |
| 107 | Chronic diarrhea (HP:0002028) | 1.95032574 |
| 108 | Dyschromatopsia (HP:0007641) | 1.93635005 |
| 109 | Arterial thrombosis (HP:0004420) | 1.93342733 |
| 110 | Hematochezia (HP:0002573) | 1.92753017 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90937331 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90937331 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90937331 |
| 114 | Pathologic fracture (HP:0002756) | 1.90760386 |
| 115 | Inflammation of the large intestine (HP:0002037) | 1.90748924 |
| 116 | Clubbing of toes (HP:0100760) | 1.90585566 |
| 117 | Skin rash (HP:0000988) | 1.90484231 |
| 118 | Skin ulcer (HP:0200042) | 1.89938624 |
| 119 | Type I transferrin isoform profile (HP:0003642) | 1.89845493 |
| 120 | Mucosal telangiectasiae (HP:0100579) | 1.89027817 |
| 121 | Mucopolysacchariduria (HP:0008155) | 1.88535922 |
| 122 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88535922 |
| 123 | Dysostosis multiplex (HP:0000943) | 1.88024243 |
| 124 | Hypergammaglobulinemia (HP:0010702) | 1.87646755 |
| 125 | Colitis (HP:0002583) | 1.85861376 |
| 126 | Leukopenia (HP:0001882) | 1.85526275 |
| 127 | Encephalitis (HP:0002383) | 1.85448593 |
| 128 | Abnormal platelet function (HP:0011869) | 1.84351287 |
| 129 | Impaired platelet aggregation (HP:0003540) | 1.84351287 |
| 130 | Thick nail (HP:0001805) | 1.83719302 |
| 131 | Glomerulonephritis (HP:0000099) | 1.83073007 |
| 132 | Hepatosplenomegaly (HP:0001433) | 1.82527731 |
| 133 | Multiple enchondromatosis (HP:0005701) | 1.80661665 |
| 134 | Keratoconjunctivitis sicca (HP:0001097) | 1.80611100 |
| 135 | Abnormality of chromosome stability (HP:0003220) | 1.79911594 |
| 136 | Joint hemorrhage (HP:0005261) | 1.79780544 |
| 137 | Amyloidosis (HP:0011034) | 1.78141133 |
| 138 | Combined immunodeficiency (HP:0005387) | 1.78047413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.96626520 |
| 2 | KIT | 3.14423250 |
| 3 | TGFBR2 | 3.09606000 |
| 4 | ERN1 | 3.04371317 |
| 5 | IRAK4 | 2.86761357 |
| 6 | MAP3K14 | 2.84505828 |
| 7 | BLK | 2.83289274 |
| 8 | RIPK4 | 2.38249480 |
| 9 | MAP4K1 | 2.37275846 |
| 10 | IRAK3 | 2.30763487 |
| 11 | STK10 | 2.18670076 |
| 12 | TBK1 | 2.10510271 |
| 13 | IKBKB | 2.10248332 |
| 14 | MATK | 2.09875604 |
| 15 | * CSF1R | 2.03376059 |
| 16 | TYK2 | 2.00968908 |
| 17 | ADRBK2 | 1.92886270 |
| 18 | GRK7 | 1.89917774 |
| 19 | GRK6 | 1.86395422 |
| 20 | JAK3 | 1.81417233 |
| 21 | GRK5 | 1.81101080 |
| 22 | PIM2 | 1.67144219 |
| 23 | IKBKE | 1.59643335 |
| 24 | BTK | 1.57594209 |
| 25 | TEC | 1.57269882 |
| 26 | FLT3 | 1.56569356 |
| 27 | NME2 | 1.43240073 |
| 28 | GRK1 | 1.43106720 |
| 29 | TAOK3 | 1.43042883 |
| 30 | TNK2 | 1.37228491 |
| 31 | PIK3CG | 1.37074081 |
| 32 | MOS | 1.34939807 |
| 33 | CSK | 1.32758104 |
| 34 | ZAP70 | 1.32715411 |
| 35 | MAP3K12 | 1.31880441 |
| 36 | EIF2AK2 | 1.31393567 |
| 37 | TXK | 1.27459573 |
| 38 | PTK2B | 1.24643611 |
| 39 | SYK | 1.23119319 |
| 40 | CHUK | 1.19695017 |
| 41 | MAP2K3 | 1.11314603 |
| 42 | PIM1 | 1.11160871 |
| 43 | PAK4 | 1.09753262 |
| 44 | FGFR3 | 1.07790631 |
| 45 | LYN | 1.07438921 |
| 46 | SIK3 | 1.05944247 |
| 47 | BMX | 1.01869581 |
| 48 | JAK1 | 1.00865470 |
| 49 | NEK9 | 1.00178951 |
| 50 | MYLK | 1.00122805 |
| 51 | MAP3K13 | 0.99624676 |
| 52 | STK4 | 0.98771119 |
| 53 | TESK2 | 0.98636769 |
| 54 | CDK7 | 0.96913811 |
| 55 | LCK | 0.96668903 |
| 56 | TTK | 0.96341007 |
| 57 | CLK1 | 0.95537263 |
| 58 | MAP3K1 | 0.93594527 |
| 59 | TRPM7 | 0.92550599 |
| 60 | MST1R | 0.90679693 |
| 61 | PDK1 | 0.90155205 |
| 62 | * HCK | 0.90072475 |
| 63 | MAP3K2 | 0.88870248 |
| 64 | PRKG2 | 0.86936791 |
| 65 | EPHB1 | 0.86595471 |
| 66 | MAPK7 | 0.86042698 |
| 67 | STK3 | 0.79012572 |
| 68 | RPS6KA4 | 0.78108072 |
| 69 | YES1 | 0.77327054 |
| 70 | ITK | 0.76681579 |
| 71 | JAK2 | 0.76437021 |
| 72 | PDPK1 | 0.73095563 |
| 73 | EIF2AK1 | 0.72384842 |
| 74 | MAP3K11 | 0.71698978 |
| 75 | ACVR1B | 0.68676438 |
| 76 | PRKCD | 0.67329985 |
| 77 | HIPK2 | 0.59700294 |
| 78 | IRAK2 | 0.59429898 |
| 79 | MAP3K5 | 0.59208555 |
| 80 | FES | 0.58912229 |
| 81 | ABL1 | 0.57522360 |
| 82 | PRPF4B | 0.56668535 |
| 83 | WEE1 | 0.56548681 |
| 84 | PRKCQ | 0.56327083 |
| 85 | TAOK2 | 0.54879061 |
| 86 | EPHA3 | 0.54593755 |
| 87 | KSR2 | 0.54231429 |
| 88 | CAMKK2 | 0.53486299 |
| 89 | MAPKAPK2 | 0.53286350 |
| 90 | MST4 | 0.53269638 |
| 91 | CDK6 | 0.52913125 |
| 92 | PBK | 0.52726995 |
| 93 | MAPK12 | 0.51906578 |
| 94 | ARAF | 0.51522841 |
| 95 | TAOK1 | 0.50411083 |
| 96 | ABL2 | 0.50389140 |
| 97 | BMPR2 | 0.49857165 |
| 98 | CDK4 | 0.49425817 |
| 99 | EGFR | 0.47764942 |
| 100 | NEK2 | 0.46656499 |
| 101 | * FYN | 0.46546265 |
| 102 | CAMK4 | 0.46466384 |
| 103 | CAMK1D | 0.46086854 |
| 104 | TGFBR1 | 0.45602053 |
| 105 | RPS6KB2 | 0.44974245 |
| 106 | STK24 | 0.44552822 |
| 107 | MAP3K3 | 0.44374381 |
| 108 | ATR | 0.43782663 |
| 109 | MAP2K6 | 0.43421117 |
| 110 | MARK3 | 0.42650780 |
| 111 | SCYL2 | 0.42368150 |
| 112 | PLK1 | 0.42201697 |
| 113 | LRRK2 | 0.40957989 |
| 114 | ILK | 0.37868128 |
| 115 | RAF1 | 0.37628940 |
| 116 | DYRK3 | 0.36282039 |
| 117 | IRAK1 | 0.35696125 |
| 118 | FER | 0.35413807 |
| 119 | FGR | 0.34645799 |
| 120 | BRSK2 | 0.34016916 |
| 121 | CDK19 | 0.33359785 |
| 122 | MAPK11 | 0.33025862 |
| 123 | * IGF1R | 0.32926974 |
| 124 | ADRBK1 | 0.32616005 |
| 125 | MAP3K6 | 0.32118078 |
| 126 | CHEK2 | 0.31640383 |
| 127 | PRKD1 | 0.31255712 |
| 128 | CDC42BPA | 0.31034517 |
| 129 | RPS6KA6 | 0.30995832 |
| 130 | MAPK4 | 0.30350323 |
| 131 | CDC7 | 0.29592891 |
| 132 | MAPKAPK3 | 0.29138445 |
| 133 | DAPK2 | 0.29025889 |
| 134 | AURKB | 0.28183027 |
| 135 | FGFR4 | 0.27605462 |
| 136 | MAP3K8 | 0.27175510 |
| 137 | ZAK | 0.25664690 |
| 138 | MAP3K10 | 0.23972312 |
| 139 | EIF2AK3 | 0.23815414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.03774844 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.39366787 |
| 3 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.26759360 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23830160 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23029194 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.22661506 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19610440 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.16268602 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.10865890 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.09929150 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93885945 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.91994291 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91667396 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90291874 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.81274878 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.80131699 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76067760 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.74811039 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74691641 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.71282585 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.67370400 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.66917624 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.61787161 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60857775 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.58181413 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.55273287 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50980062 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44969057 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.41964846 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39462204 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38010962 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35723717 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30262985 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.29516608 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27298042 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24677529 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.21338010 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.20174296 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.19409654 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18196840 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.17208122 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.16891384 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15100396 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12858794 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11022452 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.08034027 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 1.07211221 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.07086175 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05161288 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04637604 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03462465 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03378149 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.02393295 |
| 54 | Mismatch repair_Homo sapiens_hsa03430 | 1.01584867 |
| 55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97070780 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95369058 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93169344 |
| 58 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92022293 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.91100937 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90293316 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88870293 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.87062981 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86209826 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84341335 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82310446 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81125596 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80613710 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75622303 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.75329011 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73411519 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72898778 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.72739423 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69562230 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67725341 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67638916 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67546358 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66164531 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65847075 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64527958 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63732588 |
| 81 | Ribosome_Homo sapiens_hsa03010 | 0.63571555 |
| 82 | Cell cycle_Homo sapiens_hsa04110 | 0.62250018 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61113292 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60977675 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59816537 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57918015 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54441629 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54096832 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53745497 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51036788 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49113842 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48804514 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48451424 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48426386 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47741541 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46840757 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46404248 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45914321 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43199517 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42601530 |
| 101 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41969690 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.41894884 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40099138 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38750750 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38184452 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38134163 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37847644 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37434261 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37394719 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.37258071 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36813134 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35990730 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35334926 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34781085 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34336237 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33027894 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32824776 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32401911 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32383022 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28069662 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26807087 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24077586 |
| 123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22174018 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21748149 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21392246 |

